Milestone Scientific (MLSS) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Market Cap: $40.2MFounded: 1990HQ: Livingston, United States

Sector Ranking#81 in Digital Health & Biotech SaaS

Overview

Milestone Scientific is a commercial-stage medical technology company with a mission to replace subjective, manual injection techniques with objective, computer-controlled systems. Its core achievement is the development of the proprietary Dynamic Pressure Sensing (DPS) platform, which powers its marketed products for dental anesthesia and epidural placement. The company's strategy focuses on driving adoption through clinical evidence, geographic expansion, and leveraging new billing codes, while navigating challenges in capital markets and sales execution in a competitive device landscape.

Pain ManagementDental Anesthesia

Technology Platform

Dynamic Pressure Sensing (DPS) technology providing real-time, objective feedback on tissue pressure during needle advancement for precise local anesthetic delivery and epidural placement.

Funding History

1

IPOUndisclosedUndisclosedJun 15, 1996

Opportunities

The establishment of a dedicated CPT code (0777T) for its CompuFlo system creates a clear reimbursement pathway in the large hospital market.

Growing clinical evidence and a focus on patient experience differentiation provide tailwinds for displacing the manual syringe in dental practices globally.

Risk Factors

Slow clinician adoption against entrenched, low-cost traditional techniques poses a persistent commercial challenge.

As a micro-cap public company, limited financial resources and liquidity create execution risk in scaling sales and marketing efforts effectively.

Competitive Landscape

Faces intense competition from the universal, near-zero-cost standard of care: the manual syringe for dentistry and the loss-of-resistance technique for epidurals. Other computer-controlled devices exist in dentistry, but Milestone's primary battle is against clinician inertia and proving a compelling return on investment for its capital equipment.